Affymax, Inc. (AFFY)
Affymax, Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in New York City, NY, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $59,984. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -1053.6%. Its beta of 7.43 implies it has historically moved more than the broad market.
Affymax, Inc. presently lacks any substantial operational activities. In its earlier history, the firm concentrated on the creation of pharmaceutical agents designed to improve therapies for severe and frequently fatal health issues across the United States. Established in 2001, its corporate base is situated in New York, New York.
Affymax, Inc. is most often compared with the following Healthcare names: